Therefore, our study aimed to investigate the basis for therapeutic approaches to target LSD1 and elucidate the mechanistic role of LSD1-H3K4 signaling pathway in ALS pathogenesis. The gene discussed is KDM1A; the disease is amyotrophic lateral sclerosis.